SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-095383
Filing Date
2024-08-12
Accepted
2024-08-12 16:00:19
Documents
68
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q glto-20240630.htm   iXBRL 10-Q 1451966
2 EX-10.1 glto-ex10_1.htm EX-10.1 65574
3 EX-10.2 glto-ex10_2.htm EX-10.2 29327
4 EX-31.1 glto-ex31_1.htm EX-31.1 18935
5 EX-31.2 glto-ex31_2.htm EX-31.2 18948
6 EX-32.1 glto-ex32_1.htm EX-32.1 15307
  Complete submission text file 0000950170-24-095383.txt   6010465

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT glto-20240630.xsd EX-101.SCH 891284
71 EXTRACTED XBRL INSTANCE DOCUMENT glto-20240630_htm.xml XML 917760
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39655 | Film No.: 241196611
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)